argenx
Susan Begelman has over two decades of work experience in the healthcare and pharmaceutical industries. Susan has held various executive positions at Genentech, including Vice President roles in Respiratory/Influenza, US Commercial Portfolio Organization and Neuroscience/Rare Blood Disorders/Influenza/Established Products, US Medical Affairs. Prior to Genentech, they worked as Director of Medical Sciences at Nuvelo, Inc. Susan also has experience as a Staff member in the Department of Cardiovascular Medicine at Cleveland Clinic. Susan is currently serving as the Vice President of Global Medical Affairs and Evidence Generation at argenx.
Susan Begelman has a Doctor of Medicine (MD) degree from Drexel University College of Medicine and a Bachelor of Arts (BA) degree in Biology from the University of Pennsylvania.
This person is not in any offices
argenx
32 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...